170 44% increase in patient numbers, what is happening out there?

Welcome

Hello and welcome to this week’s episode of the Treat Your Business podcast. I’m so excited for today’s conversation because we’re continuing on from a couple of recent episodes about the shift in patient behaviour, what people want more of now in their rehabilitation and care, and why trust and choice matter.

This one is a little different from our usual strict business advice. It’s about what’s changing in the industry, the exciting developments in medical technology, what is being taught at university, and what our new graduates may be expecting from us inside our clinics.

Episode Summary

I’m joined again by Liz Clare and Dr Anna Schreiner to talk about what is happening with MBST, why demand is rising, and what the future could look like for conservative care.

We cover MBST’s expansion into new countries, why more patients want to avoid surgery, and how MBST can complement other modalities already used in clinic. We also talk about education and access in the UK, including the University of East London project and why community programmes and research matter.

Key Takeaways

• More patients are questioning the ‘default’ options and looking for conservative care.
• MBST is expanding internationally, with growing interest in regenerative approaches.
• UK demand is rising, alongside a bigger push for education and research.
• The University of East London project is focused on learning, data, and community access.
• MBST can complement existing clinic toolboxes rather than replace them.

Resources & Links

• Connect with Liz Clare on LinkedIn
• Connect with Dr Anna Schreiner on LinkedIn
• Follow MBST UK on social media

Thanks for listening to the Treat Your Business podcast. Hit subscribe and keep joining me for bigger insights and bolder conversations to help you build a clinic and a life you love.

Treat Your Business podcast is proudly sponsored by MBST, the groundbreaking technology revolutionising recovery and rehabilitation. Offering a non-invasive, drug-free solution for musculoskeletal conditions and nerve injuries, MBST works at a cellular level to stimulate regeneration. Expand your services and deliver long-term patient improvements without increasing your workload.

Learn more at mbstmedical.co.uk. 

Come and join me over on YouTube https://www.youtube.com/@thrivebizcoach?sub_confirmation=1  

Resources & Links:

Foundations Programme: https://join.thrive-businesscoaching.com/foundations

🔗 If you are ready to get ahead, you will find all the essential resources and links you need right here: our Linktree

• Leave a review!: https://ratethispodcast.com/tyb 
• Subscribe to our Channel on Youtube: https://www.youtube.com/@thrivebizcoach?sub_confirmation=1

Transcript

Treat Your Business EP170

[00:00:05] Katie Bell: ​Hello and welcome to this week's episode of the Treat Your Business podcast. Super excited for this conversation today because we are continuing on from a couple of episodes that we have already recorded around the change to I guess. Patient behavior and what patients are wanting more of now in terms of their their rehabilitation and their care.

[00:00:26] Katie Bell: And perhaps this is a a kind of fallout of, of [00:00:30] the pandemic and, and trust issues and people wanting to ask more questions and avoid being in hospital. But this episode is a little bit different from, from normal, not strict business advice, but it's really about, us leaning into what's changing in the industry the exciting changes in medical technology, what is being taught at university and I guess what our graduates and our newly qualified that are coming through, we're gonna be expecting perhaps of us within our clinics.

[00:00:58] Katie Bell: So pull up a chair, grab a cup of [00:01:00] tea. Enjoy this episode.

[00:01:02] Katie Bell: Welcome to the Treat Your Business podcast, the show for clinic owners who want real, honest advice and tried and tested ways of doing things. I'm Katie Bell, and this is the new era of bigger insights and bolder conversations to help you grow a clinic and a life you love. Let's dive in.

[00:01:20] Katie Bell: Hello ladies, welcome back to the Treat Your Business podcast. 

[00:01:24]  Liz Clare: Thanks for having us again, Katie, thank 

[00:01:27] Katie Bell: you for being here and for having the opportunity to [00:01:30] continue our conversation now. We recorded a podcast a few months ago now, and if you haven't listened to that one, I would encourage all of you listeners to go back and listen to that.

[00:01:39] Katie Bell: I think it was a great introduction to MBST Dr. Anna, you provided your wealth of knowledge within a very short space of time, which was great. So I would encourage people to go back and listen to that. So Liz and Dr. Anna, thank you again for being here.

[00:01:52] Katie Bell: I know we want to talk about the, the kind of evolution of MBST and what's about to happen in terms of its [00:02:00] expansion. And, things that are going on across the world, but also in the uk. So Dr. Anna, do you want to explain what is happening behind the scenes? What can we all be excited about? 

[00:02:10] Dr. Anna Schreiner: Yeah.

[00:02:10] Dr. Anna Schreiner: Thank you so much Katie. Thanks again for having us here. It's always such a pleasure to talk about MBST and spread the word, so yeah, actually it's quite exciting times for MBST. So we are now partnering up with new countries. We're diving into emerging markets. So I've just recently been to Singapore and India.

[00:02:28] Dr. Anna Schreiner: So we have now [00:02:30] opened up centers in Mexico and Honduras, for example. We are exploring South American options in Southeast Asia. We've been talking to experienced users, rheumatologists and a clinic, met with new possible partners. Same for Indonesia, Malaysia, which has just started. Also, Vietnam is a very promising country with strong interest in advancing in combination therapy.

[00:02:50] Dr. Anna Schreiner: And in India, interestingly, we we talk to let's say major hospital group. So it's, it's a big market with a huge need for conservative [00:03:00] treatment. And this. Also allows us for doing great studies there. But yeah, so this is sim I think has been a growth for our company up to 30% last year. And also when I attend all those conferences and talk to more and more healthcare practitioners and colleagues about MBST, there's.

[00:03:15] Dr. Anna Schreiner: Really raising more and more awareness for conservative treatment options for being able to think outside the box and think about which kind of things in my toolbox might be still needed. So perhaps we can talk a little bit later [00:03:30] about those regenerative medicine, and it's such a promising future for medicine.

[00:03:35] Dr. Anna Schreiner: General of therapy or this kind of neuro therapeutic approach. And I think we're quite proud to, to con contribute with, with MBST to the journey. But I think especially for the uk it's really, it has been a fascinating journey so far. It's quite, quite good to see in which direction we are moving.

[00:03:52]  Liz Clare: I was gonna say that patient demand, even for MBST from the start of January to today. [00:04:00] I would, our patients' numbers have gone up 44% from last year. So even just people recognizing or the need or Yeah, more and more patients, you know, which is huge. You know, 44% from this time last year, it's, and we are opening, we've, we've finally employed a sales person as well.

[00:04:18]  Liz Clare: We've never had a sales department, so yay. We need one. So yes. Anyone inquires about an MBS T machine now? You actually get looked up. No, I'm really joking. Of course. You always get looked up. We [00:04:30] actually can deal with the inquiries now because last year was just off the scale. But yeah, so back to Anna taking it back.

[00:04:37]  Liz Clare: It really is an exciting time and there's so much coming and Anna's gonna tell you more about it now, but I just had to tell you how great it's going in the UK right now, since the beginning of January. 

[00:04:47] Katie Bell: That's so exciting. This is this funny principle that I call traction, where in a business where you feel like you're doing all the legwork for so long and then all of a sudden something feels like it clicks and it, and it isn't anything that clicks, it's just that you [00:05:00] have, you have bang the drum for long enough and you've got that kind of level of visibility and, and people are now talking about it, which, you know, a year, a year ago it, people perhaps were talking about it less.

[00:05:11] Katie Bell: It's really exciting, isn't it, for you. Dr. Anna tell us some more. 

[00:05:16] Dr. Anna Schreiner: Well, you, you said something like now it seems to set off or seems to speed up, et cetera. So this also fully aligns with, let's say, my, my German or international or UK experience. And I think what I learned from my last.

[00:05:29] Dr. Anna Schreiner: Business trips, [00:05:30] which really led me to different kind of countries is that kind of agreement or let's say finding that the majority of all patients really wants avoid surgery. So this is quite encouraging that we can now present something or have some kind of the missing, missing piece in the toolbox that helps addressing that kind of need.

[00:05:51] Dr. Anna Schreiner: I mean, MSK also from a socioeconomic standpoint is. Such a huge burden. I mean like osteoporosis, osteoarthritis chronic [00:06:00] low back pain. And what we have in our toolbox so far is okay, okay. Moderate to perhaps good, but still there is this treatment gap and wherever I come to whomever I talk to, it's always this perception of, yes we need more to help patients who want to avoid surgery or want to over bridge or gap time between surgery or.

[00:06:20] Dr. Anna Schreiner: Offer them something in, in between and to, to address that treatment gap, but also have something in your, in your pocket to, to answer that kind of need. So and [00:06:30] especially when also exploring other markets, they're quite open to what we call regenerative medicine. Some kind of a, let's say, emerging term which, which says in orthopedics or refers to treatment that aims to repair, or regenerate damaged musculoskeletal tissues by stimulating the body's own healing processes, rather than really just relieving symptoms or just replacing tissues with artificial implants.

[00:06:55] Dr. Anna Schreiner: I mean. In many cases it's needed at some point, but it's really the kind of [00:07:00] last resort and we have to offer patients more than just those kind of definitive let's say solutions. So when it comes to, and we've 

[00:07:07]  Liz Clare: great technology, sorry, an but already, you know, things like EMTT, shockwave Laser that already used in clinic, so it is just showing that.

[00:07:16]  Liz Clare: Medical technologies are being used more and more, and I'm hearing that a lot of physiotherapists coming through medical school university that they're coming through are being taught more about these technologies. And with UEL, actually MBST is gonna [00:07:30] be a module there as part of a bigger. Even bigger like data collect.

[00:07:34]  Liz Clare: But I think Anna, this is gonna be part of what she's gonna be sharing with you very soon is exactly how we are positioning alongside MBST with these other technologies. A, why it stands out, et cetera, et cetera. There's a lot of studies happening, isn't there, Anna? 

[00:07:49] Dr. Anna Schreiner: Absolutely. And I think just mentioning the neighborhood health app at, at GEL just shows also the massive need for education.

[00:07:57] Dr. Anna Schreiner: And I can tell from my background when I was was [00:08:00] still focusing mainly on, on surgery, that for me back then, conservative treatment just comprised. Some sessions of physiotherapy, ibuprofen, and that's it. And now I've learned more about all those kind of approaches in my time in the industry and like talking so to so many healthcare practitioners worldwide.

[00:08:17] Dr. Anna Schreiner: So I think our goal is obviously is. Spreading the word about this kind of therapy. But for me it's also a really big thing heartfelt to spread the word about those kind of options to treat patients in a non-invasive [00:08:30] way, which is not harmful with, with non to non side effects.

[00:08:33] Dr. Anna Schreiner: So, this is really for me, as I still do lecturing at my university, a big educational purpose as well. And this is also one of the main focuses with UEL. So it's about providing access to this kind of cutting edge science to staff, students and the neighborhood obviously but also educate.

[00:08:50] Dr. Anna Schreiner: Students and the neighborhood about what kind of options do they have as patients. It's not just this easy fix thing. So they also should know or be educated [00:09:00] about this kind of toolbox. And so that's why I like regenerative medicine or the idea a lot because it's this comprise a great toolbox.

[00:09:07] Dr. Anna Schreiner: And like you said, many practitioners already have some kind of very good things in the toolbox, but still feel okay. There might be some kind of a. Missing thing. And that's why NB where NBC fits in quite well because it tackles those kind of, let's say small or bigger deficits other modalities might have.

[00:09:25] Dr. Anna Schreiner: So with a laser, for example you cannot reach all kind or penetrate all [00:09:30] layers of the body. With shockwave, you're limited to, let's say, certain anatomic regions, you're not allowed to do it, let's say. Everywhere in the cervical region you cannot reach any kind of let's say deep down structures or goran, abdominal, et cetera.

[00:09:43] Dr. Anna Schreiner: So MBST, fits in quite well because it can really penetrate all tissues. It reaches all possible structures or layers within the body, and it allows even for a whole body treatment. So many devices usually are limited to smaller areas of treatment. And with [00:10:00] MBT, depending on the device, you can even address or tackle let's say systemic problems like osteoporosis, poly neuropathy Poly oa, et cetera.

[00:10:08] Dr. Anna Schreiner: So and you can always start with MBST because it's pain free and this actually compliments quite well your toolbox, which you already have because many say, okay, well laser does quite a lot of good things, but the problem is that it's. Limited to, let's say the, the upper or superficial layers.

[00:10:27] Dr. Anna Schreiner: And interestingly as I said we are [00:10:30] let's say. Expanding as a company, but also with regards to research, collaborations and scientific collaborations. We also now collaborate with a with a university of Munich, a very renowned scientist in the world of shockwave and laser. And he dived quite deep into all kind available preclinical and clinical data and analyze what does laser do?

[00:10:50] Dr. Anna Schreiner: And interestingly, when it comes to. Putting all those kind of, let's say, findings together. You can see there are quite interesting [00:11:00] similarities. So between magnetic resonance therapy and also laser therapy. So functionally magnetic resonance seems to correspond to photo biomodulation, which laser does with effects comparable to those of laser.

[00:11:13] Dr. Anna Schreiner: It overcomes its significant limitations through effective simulation of even deep tissue structures. And so we know about like the, the effects or mechanisms of energy redux and inflammation regulation, but this kind of let's say idea or new perspective for angle [00:11:30] probably makes it easier to understand for many practitioners why MBT works within so many.

[00:11:36] Dr. Anna Schreiner: Issues or conditions and in, in which not, because we now really can understand, let's say, stepwise better and better the complex world of magnetic resonance therapy. So yeah, you can easily access our Preprint by Professor Smith and others. I think we can probably share the link in the show notes, or it's also on our LinkedIn.

[00:11:55] Dr. Anna Schreiner: So for, for the ones who want to dive deep into, into the scientific yeah, [00:12:00] scientific background. But I think the. Bigger picture when it comes to regenerative medicine. Also comprises, let's say also biologics, which is, I mean, interesting because they also try to stimulate health in a more natural way.

[00:12:14] Dr. Anna Schreiner: So many patients probably heard about P-R-P-B-A adipose derive. Cell therapy, et cetera. There are, I think, quite interesting approaches, but especially stem cell treatments the majority is not FDA approved and a lot of those things remain [00:12:30] investigational and has got moderate evidence and also side effects.

[00:12:34] Dr. Anna Schreiner: So I always like to, before I talk about MBST or let's say any other kind of modalities. To go one step back and think about where's the difference between a pharmaceutical approach, a surgical approach, and a physical approach. And once you understand the difference of those kind of approaches you really get a better feeling for which kind of components should be in your toolbox [00:13:00] and why this or that thus this or that.

[00:13:03] Dr. Anna Schreiner: So pharmaceuticals really change biology, chemically. It interferes with the body's. Processes, quite selective. Your blood receptors interfere with cascades, so that's why you have got side effects and those polypharmacy issues. Surgery obviously changes anatomy mechanically, so it fixes those aspects.

[00:13:21] Dr. Anna Schreiner: Yet, yet it's also associated with inflammation, tissue damage, it's invasive, has got side effects. It's just, just a structural [00:13:30] intervention, but I always say our body's quite intelligent. It always aims for homeostasis, so wouldn't it be better to support and enhance this kind of inherent capacity structures and processes?

[00:13:40] Dr. Anna Schreiner: So some modern drugs and other biologics try to do that, but unlike medications or surgery, physical therapy actually works by stimulating biological duction or modulation through mechanical and biophysical stimuli and stimul So this is a totally different kind of [00:14:00] approach. And once you.

[00:14:01] Dr. Anna Schreiner: Standard, that kind of mode of action. And within this kind of family of physical therapies MBST belongs to. And I think in the future also, when we have done more and more, studies will play an even greater, greater role or more important role. I 

[00:14:15] Katie Bell: think it's fascinating how the, the behavior of society has shifted.

[00:14:21] Katie Bell: Mm-hmm. And I think, only this morning my mom arrived to look after my little boy while, while I'm working today. And she was telling me about the [00:14:30] measles outbreak in London. That's a, you know, a big thing at the moment. And it's because the rate of vaccination has reduced hugely in in children.

[00:14:39] Katie Bell: And this is a, this is a throw back from the pandemic and trust. Trust issues. And the reason I tell you this is because I think as a society, our behavior now is. Based on what we've all experienced five or six years ago, we are questioning things more. We aren't following the norm of, you know, well, let's just have [00:15:00] surgery, or let's just take these drugs.

[00:15:01] Katie Bell: We are now saying, well, is there a different approach? Is there something better? Is there something more holistic? You know, that that works. For me rather than just accepting this is the way we, we do, we have always done things. You take some drugs, you reduce your pain and we see how long we can last before you basically need a new replacement or, you know, you need surgery of some of something.

[00:15:22] Katie Bell: But that comes with huge risks. People don't want to be in hospital you know, because of everything else that's going on within hospitals and all the other infections [00:15:30] and things. So it feels that. Society's behavior in terms of how they want to be treated and what, what they're looking for now to solve their problem has shifted.

[00:15:40] Katie Bell: And I guess that's why we're probably now seeing Liz, this huge 44% increase you know, in, in patient numbers. 

[00:15:47]  Liz Clare: Absolutely. And I think building the awareness as, as well, you know, we are trying to, our social media's changed a bit, much more sports focused because we're getting more sports data and I think if you're on Instagram it's more the sporty sort of people are on there.

[00:15:59]  Liz Clare: So we're just, we've [00:16:00] found like an uplift even from people following us and interacting with others as has changed. So we're trying a bit more tactful in how we do do word of mouth. But what I really think is gonna be the big game changer for the UK and its people is. The project we've got with University of East London, I dont know how much we spoke about it in our previous conversation, but we touched on it earlier about becoming a module one, the physios, but what's the most greatest thing?

[00:16:25]  Liz Clare: We are part of their neighborhood health hub and that is making healthcare accessible [00:16:30] to the community and a certain place. Of East London, Newham. And with that, we'll be treating, giving free access to MBST with those people in those postcodes so we can treat a number of people that wouldn't normally be able to afford the technology.

[00:16:44]  Liz Clare: And Anna is doing an incredible job with the team there in order to create the study protocols and what we are, the information we are gathering are also then going to be doing it throughout all our current clinics as well. So we've got this huge data drive coming. So we can further and further [00:17:00] spread the word and influence the right people such.

[00:17:02]  Liz Clare: Wes streeting, when he met the technology in October was just really quite overwhelmed by it to the point he changed his speech last minute mm-hmm. To talk about necessarily name MBST and not allowed, but talk about what the tech machines they've seen. And he said, wow, what this could do, you know, getting Britain back working a solution for bone health.

[00:17:21]  Liz Clare: That doesn't mean you know, things too costly. So. We've got the great, sports stuff. We've got the sports studies that are gonna be coming out soon with like, we've got [00:17:30] Liverpool football club, bath rugby Charlton athletic Wrexham football club.

[00:17:33]  Liz Clare: They're all working hard getting all this data to us. But I think this community project showing what we can do, not just for those at the moment, 'cause it's private care, but what it can do for everybody from all walks, walks of life is what's really important to us. And yes, fair enough. It probably will be in private health for quite a while.

[00:17:51]  Liz Clare: But, you know, and where will it end up going? We don't know, but it's just about building the recognition, the trust that this technology is the [00:18:00] future. 

[00:18:01] Katie Bell: Yeah. Yeah. I, I, I strongly believe it is. And I think interesting. , I was with some patients of mine who I've been patients of mine for years yesterday, and they wanted to meet my little boy.

[00:18:10] Katie Bell: So I went out to, I drove out to see them ever so cute. And I was telling them about MBST He's got osteoarthritic knees, she's got osteoarthritic hip. And I was explaining, you know, in my terms to it, and they were just blown away by the conversation I was having because they have invested in me.

[00:18:29] Katie Bell: [00:18:30] For 15 years to try and keep them away from surgery. And everything that we have done has, has, you know, has had a great impact on them. But they're aging. They're, you know, thinking, you know, how long is this? And, and there's always been this kind of tool in the toolbox for me. I was explaining to the Anna, you used the exact words that I felt has always been missing.

[00:18:51] Katie Bell: You know, acupuncture getting used to do some strengthening work. We're do, I'm trying to do all of these different things, but ultimately, am I making [00:19:00] any difference at cell level? No. You know, not, I'm not whereas, you know, the introduction of of this technology, it just changes the landscape completely.

[00:19:11]  Liz Clare: And that's MBST couldn't work without great practitioners like yourself, like identifying how to work with it. That's what's important process like. Yes. MBST can identify the tissue and structurally do that. At cell level, but it still needs, well, one of our physios, he always says it's like, just think that MBST is the [00:19:30] ingredient and healthcare professional shows the body how to use it, and it's the best way of putting it.

[00:19:35] Katie Bell: Nice. Yeah. Yeah. It doesn't replace everything else, does it? You know, it all still has a, has a place and we're, we are seeing more and more push into rehab and, and, you know, exercise-based prescription and, and all, all have their place in some. Respect, but this is about I guess a, for me, a kind of a deeper level of care, a more, [00:20:00] you know, it's really a deeper level of care for our patients, isn't it?

[00:20:03] Dr. Anna Schreiner: It is, and I think this is also why we are getting not tired of saying health starts in the cell because this kind of technology actually allows for really targeting the root cause, targeting cellular health, going down to that kind of, let's say not only deep level regarding, let's say anatomic structures, but really addressing those various processes metabolism aspects, et cetera.

[00:20:28] Dr. Anna Schreiner: It can be stimulated in a [00:20:30] very sustainable way. So that's why we do not say it's throw away the rest of your toolbox. No, it's really complimenting it quite well. I mean, even when it comes to, to pen, for example this can be considered as MBST. Little brother. So you can always start with that.

[00:20:45] Dr. Anna Schreiner: It's good for acute symptoms. I had it when I had my ankle sprain, but when I repeated it like two or three weeks later, it did not show any effect. So for you can always start with, let's say some things, but especially with MBST because it's pain free, but when it comes [00:21:00] to readjusting your cellular clock, et cetera and want to have, like you said, those kind of.

[00:21:04] Dr. Anna Schreiner: Sustainable effects, which, which really affect, let's say the core of the problem. You now have something you can add on and and offer to your patients. So, like you said, it it's some kind of the missing piece. And interestingly it. Even lots of our users have made the experience that what they did so far, let's say the standard protocols so far enhances with MBST.

[00:21:27] Dr. Anna Schreiner: So especially when it comes to shockwave or even [00:21:30] laser they see, well, my shockwave results get better in combination with MBST and I think, we are still in, in the learning process. Also from a, a research and scientific standpoint, it's, it's so exciting times, I think also for, for new knowledge, which will come up and new studies, which we will do.

[00:21:48] Dr. Anna Schreiner: And when I do, let's say my, my, my bigger lectures and also educate people about physical therapies and if you look into what's happening in the research world. So many scientists are now [00:22:00] interested in what do low magnetic fields do? What does laser light, et cetera do? So they now see, like I said before, that those, this kind of approach really seems to stimulate the body in a much more natural way.

[00:22:12] Dr. Anna Schreiner: And enhances those kind of let's say processes towards homeostasis, probably much better than let's say what we did so far. And so that's. The good thing about medicine, it's always evolving. There's always gonna be new knowledge, which can be incorporated. In our daily practice, that's where it's needed.

[00:22:29] Dr. Anna Schreiner: So [00:22:30] publications are good, but in the end, our patients need better care and better treatment. And so yeah, this is what makes me happy to have something we can offer to say achieve more sustainable results, adjust cell health and be a, be just, be a good partner. In a setup and even lead to better results.

[00:22:48]  Liz Clare: I know I keep bringing it back to the sport, but I think you know what we, with, when you look at the medical teams, they have their strict protocols, don't they? They have everything they use day in, day out and then when they add in [00:23:00] MBST, I wish I could share some of the headline data now with you. I dont know, Anne, if you've got any of the chart, we could sneak some of it out, but it is weeks. It's weeks and weeks off. And each issue has its own sort of timeframe, which is really interesting. So how much MBST is saving the return to play, getting that player back if, when compared to is data? 'cause you'll never be able to do a placebo based study with an athlete because they can't afford to do that.

[00:23:25]  Liz Clare: But what they can show is throwing everything at the athlete that they normally do. Adding [00:23:30] MBST in is the only different within reason as much as you can control. The significance is weeks off an injury. It's amazing. It truly is. 

[00:23:39] Katie Bell: Well, interestingly, Liz because I happen to know that MBST is used at Bath in, in bath rugby club, isn't it?

[00:23:46] Katie Bell: Yes. And my husband is a huge rugby rugby fan. Like he knows every player's name. It's like, you know, fantasy football. He, we, rugby is on the television. All the time. Okay. He knows everything that you need to know about [00:24:00] rugby. He knows it. And he happened to say there was a player in Bath that got injured.

[00:24:04] Katie Bell: I don't even know what injury it was, but it was quite significant. And he was back really quick and my son was like, he's back. Like, you know, 'cause I'm always talking about injuries and things. He said he's returned to play, you know, really quickly, which is obviously great for Bath. And I, I, I, I was sat in the kitchen, he was telling me this and I was like, I wonder if I said, I just wonder if maybe he's had some MBST thrown at him and the change in that.

[00:24:27]  Liz Clare: It's probably one of our case studies that we can share. [00:24:30] No, it's amazing. 'cause we had. What was really lovely for us is that there was a got, he was meant to be out for so long, but we managed to get him back. Say, we like, and, and Bath Rugby's amazing rehab team. We can't just take all the credit. He got back that much faster that he got them picked for wales for the first time.

[00:24:48]  Liz Clare: And I think things like that, the knock on effect that that has is what's so huge. And I think there's also one for England as well. And it just makes you feel, oh, gotta get emotional. Like it's more, it's more, it's, you're impacting people's lives even from [00:25:00] that. You know, 

[00:25:01] Katie Bell: it's, it, it was, it was exactly that one, Liz, because my husband's a welsh class, so it's this

[00:25:04] Katie Bell: we're talking about. Yeah. But, you know, that's incredible, isn't it? That you know, he's spot, he was like, wow, I wonder how, you know, he's, he's, you know, returned back so, so much so that, you know, the, the conversation now is when are you buying one? Like, we need one of these.

[00:25:16] Katie Bell: We need one of these in our house. You know, 

[00:25:19]  Liz Clare: get more rugby players on it. There. We'll be presenting this. Data, you know, the time is right. We've got enough. We will, and, you know, and these healthcare professionals at the [00:25:30] clubs are willing and wanting to talk about it more. So it's really great for us.

[00:25:34]  Liz Clare: Really is. 

[00:25:34] Katie Bell: Maybe you'll be on the next Wrexham Netflix documentary 

[00:25:38]  Liz Clare: we have. It says, we, we were on it for about, well, not me personally, but the machine was in it for about three seconds the last season. 

[00:25:47] Katie Bell: Watch, get back and watch it. So this really feels very exciting and I think. I dont know whether I'm wrong in saying this, and forgive me if I am, but I sometimes feel like the UK lags behind [00:26:00] in, in, in our approach to regenerative medicine and being open to perhaps these technologies, you know, you, you kind of experience people like going.

[00:26:11] Katie Bell: Spain and Germany, and they seem to have access to much more of this stuff than we do. And we are very pharmaceutical led and surgical led in the uk. Maybe this is just a observation of mine and it's completely wrong but it feels exciting that we are finally in Oh, 

[00:26:26]  Liz Clare: mindset's changing for sure. 

[00:26:28] Katie Bell: Yeah.

[00:26:28] Katie Bell: The mindset is changing [00:26:30] and, and, and that's a exciting place to be at, I'm sure for, for both of you 

[00:26:34]  Liz Clare: maybe is it sad because it might be 'cause of the distrust from conventional medicine, who knows? Maybe, and, and more and more technologies like this are being used, you know, there's growth that way. I, I think that, I think both from both sides, it's growing.

[00:26:48] Katie Bell: Yeah. 

[00:26:48] Dr. Anna Schreiner: And I think it's, it's a need from, from different. From all kind of sites like patients, but also practitioners and I think the healthcare system itself and in the United States there's a paper about, or [00:27:00] even, let's say an approach, which is called Whole Person Health because they they realized they spend so much money on their healthcare system, and it's similar in Germany, uk, Europe, all over the world.

[00:27:09] Dr. Anna Schreiner: That the, the return of in West Health Wise seems not to be appropriate. So, more and more people now, see what probably we have to adapt the current running system because it does not lead to the results we we actually want to have for our patients. So patient-wise, they are actually want to avoid any kind of invasive treatments.

[00:27:28] Dr. Anna Schreiner: And I think nowadays more [00:27:30] information is available out there. And also the mindset changes more towards health, not just treating symptoms, but the whole longevity discussion is about how can I be healthy longer and not just, yeah. Or do I do once, once I'm sick. So I think this is some kind of a change of mindset, but also when I look at the medical side, but also like, like I told you the research side there's much more growing interest now in which other kind of approaches are available.

[00:27:55] Dr. Anna Schreiner: And also education wise at the universities are even during my [00:28:00] residency, the mo, the main focus was. Quite, let's say, limited to this one and only approach, but I, a good doctor, you, you have to think about other kind of approaches. You want to have a tailored, more individual approach to your patient in the end and not a one size fits all.

[00:28:15] Dr. Anna Schreiner: So it's so much about education and especially. We speaking for Germany, for example, as a doctor, when you leave the hospital environment and decide to open a practice there is not much education around telling you which kind of toolbox is [00:28:30] good, which kind of elements are quite nice. So you really depend on education people.

[00:28:34] Dr. Anna Schreiner: Spreading the word about this or that, and now there's so much more growing evidence in the whole sector of regenerative medicine. There's many interesting conferences and conferences you can attend nowadays with them. And knowledge spreads faster, but you also have to be cautious, obviously, at the same time to check whether evidence is good or not.

[00:28:51] Dr. Anna Schreiner: And we are also working on that because we know cell data is good. Clinical data is older. We have to update some things. But yeah. It's also [00:29:00] fun because we are, we are growing when it comes to science and knowledge. And that's also exciting for me because it is like, every day I learn, learn more about those kind of approaches and how we can at the end of the day transfer it into a clinical practice and help our patients.

[00:29:14] Dr. Anna Schreiner: So it's very exciting. 

[00:29:16] Katie Bell: It's a fulfilling job for you, Dr. Anna For those listeners who maybe haven't listened to the first episode, I'm gonna encourage you to go back and, and listen to that again. I also interviewed two fabulous [00:29:30] gentlemen on another episode which was great fun, and they are using it within their clinics, and we had some really great conversations about how it actually works in your clinic and and really got into the nitty gritty there.

[00:29:40] Katie Bell: So I'd encourage you to go back and listen to that episode as well. Dr. Anna Liz, if people are kind of wanting to explore this further, what, what do they do next? Where do they go? 

[00:29:50] Dr. Anna Schreiner: I would follow, come and find us on LinkedIn, Liz, Claire and Anna Shriner. We are doing a lot more webinars.

[00:29:56] Dr. Anna Schreiner: Anna's actually got her first one this Friday, but probably by the time this is [00:30:00] out it we've got, but there will be more and more because it's all about education now and focus and, and releasing data as and when. So do, because we. I'm actually using my LinkedIn a lot more myself, so, mm-hmm. We just try to keep everyone up to date and actually it is such a good tool.

[00:30:16] Dr. Anna Schreiner: It really is quite impactful and yeah, so come find us on LinkedIn. We've got at MBST UK on all our social medias, but I think from a. From us to our he other healthcare professionals. LinkedIn is the tool at the moment for all our [00:30:30] conversations like that. All our social media tends to be more for the patient.

[00:30:33] Katie Bell: Yeah. Great. Okay. Amazing. Well, I encourage, I encourage you if you are even just slightly interested or curious to understand a little bit more to reach out to, to Dr. Anna and, and to Liz on LinkedIn. Thank you ladies for giving up your very valuable, very, very valuable time to come on the. Treat your business podcast and just to kind of inspire our listeners to think outside the box a little bit more and and be excited about what the future holds.[00:31:00] 

[00:31:00]  Liz Clare: Yeah, all conversations are always welcome.

[00:31:02]  Liz Clare: Thanks for listening to the Treat Your Business podcast. Hit subscribe now and keep joining me for bigger insights, older conversations to help you build a clinic and a life you [00:31:30] love.